期刊文献+

早期非小细胞肺癌患者术后化疗依从性影响因素分析 被引量:10

Analysis of Influencing Factors of Postoperative Chemotherapy Compliance in Patients with Early Stage Non-small-cell Lung Carcinoma
下载PDF
导出
摘要 目的探讨早期非小细胞肺癌患者胸腔镜肺癌根治术术后辅助化疗与常规开胸手术后辅助化疗的依从性。方法选取2001年1月至2009年12月第二军医大学长征医院胸外科收治的临床ⅠA期非小细胞肺癌患者共267例,其中,45例非小细胞肺癌患者需进行术后辅助化疗,纳入本次研究。按照患者术后化疗依从性将患者分为未化疗(14例)、部分化疗(5例)和充分化疗(26例)。比较患者术后化疗实施情况,分析术后化疗完成依从性对非小细胞肺癌患者术后长期无瘤生存率的影响。结果术后病理分期N1及以上患者45例,其中31例进行了术后辅助化疗,26例完成了4个周期。logistic回归分析显示,化疗依从性随着年龄升高而逐步降低,胸腔镜手术可提高术后辅助化疗的依从性,但并非唯一影响因素。术后辅助化疗依从性对于术后长期无瘤生存率的影响差异无统计学意义。结论对于临床ⅠA期非小细胞肺癌患者,胸腔镜肺癌根治术术后辅助化疗的依从性要好于常规开胸手术。 Objective To explore the adjuvant chemotherapy compliance between thomcotomy and videoassisted thoracoscopic surgery(VATS)in the treatment of early stage non-small-cell lung carcinoma(NSCLC).Methods Two hundred and sixty-seven patients with early stage NSCLC who were treated in our hospital between January 2001 and December 2009 were divided into the VATS group(n=115)and the open thoracotomy group(n=152).Analyze the factors leading to discontinue adjuvant chemotherapy in the nodal upstaging of clinical stageⅠ A NSCLC.Results Unsuspected nodal upstaging was later found in 45 patients,among them 31 received adjuvant chemotherapy and 26 completed all four cycles.Ordinal logistic regression revealed that chemotherapy compliance was significantly reduced by the patient′s age and N status.Chemotherapy compliance was increased with videoassisted thoracoscopic surgery.But it was not the only influencing factor.Conclusion The adjuvant chemotherapy compliance is superior after thoracoscopic lobectomy for early stage non-small-cell lung carcinoma(NSCLC).
出处 《成都医学院学报》 CAS 2015年第3期294-297,301,共5页 Journal of Chengdu Medical College
基金 上海市科学技术委员会产学研医合作项目(No:14DZ1941306)
关键词 非小细胞肺癌 胸腔镜 辅助化疗 依从性 NSCLC VATS Adjuvant chemotherapy Compliance
  • 相关文献

参考文献23

  • 1Chemotherapy in non-small cell lung cancer:a meta-analysis using updated data on individual patients from 52randomised clinical trials.Non-small Cell Lung Cancer Collaborative Group[J].BMJ,1995,311(7010):899-909.
  • 2Arriagada R,Bergman B,Dunant A,et al.Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer[J].N Engl J Med,2004,350(4):351-360.
  • 3Pignon JP,Tribodet H,Scagliotti GV,et al.Lung adjuvant cisplatin evaluation:a pooled analysis by the LACE Collaborative Group[J].Journal of Clinical Oncology,2008,26(21):3552-3559.
  • 4Kawachi R,Tsukada H,Nakazato Y,et al.Morbidity in videoassisted thoracoscopic lobectomy for clinical stage I non-small cell lung cancer:is VATS lobectomy really safe?[J].The Thoracic and Cardiovascular Ssurgeon,2009,57(3):156-159.
  • 5Luo QQ,Lin H,Tan Q,et al.Analysis of clinical application of thoracoscopic lobectomy for lung cancer[J].World Journal of Surgical Oncology,2014,12(1):157.
  • 6Jiao W,Zhao Y,Wang M,et al.A retrospective study of diaphragmatic motion,pulmonary function,and quality-of-life following video-assisted thoracoscopic lobectomy in patients with nonsmall cell lung cancer[J].Indian J Cancer,2015,51:45-48.
  • 7Licht PB,Schytte T,Jakobsen E.Adjuvant chemotherapy compliance is not superior after thoracoscopic lobectomy[J].The Annals of Thoracic Surgery,2014,98(2):411-416.
  • 8Strauss GM,Herndon JE,Maddaus MA,et al.Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer:CALGB 9633with the Cancer and Leukemia Group B,Radiation Therapy Oncology Group,and North Central Cancer Treatment Group Study Groups[J].Journal of Clinical Oncology,2008,26(31):5043-5051.
  • 9Group MC.Adjuvant chemotherapy,with or without postoperative radiotherapy,in operable non-small-cell lung cancer:two meta-analyses of individual patient data[J].The Lancet,2010,375(9722):1267-1277.
  • 10Winton T,Livingston R,Johnson D,et al.Vinorelbine plus cisplatin vs.observation in resected non-small-cell lung cancer[J].New England Journal of Medicine,2005,352(25):2589-2597.

同被引文献115

  • 1骆宏,叶志弘,王菊香.聚焦解决模式在临床护理中的应用[J].中华护理杂志,2007,42(6):568-570. 被引量:267
  • 2Swanson S J,Meyers B F,Gunnarsson C L,et al.Video-assisted thoracoscopic lobectomy is less costly and morbid than open lobectomy:a retrospective multiinstitutional database analysis[J].Ann Thorac Surg,2012,93(4):1027-1032.
  • 3Gonzalez-Rivas D,Paradela M,Fernandez R,et al.Uniportal video-assisted thoracoscopic lobectomy:two years of experience[J].Ann Thorac Surg,2013,95(2):426-432.
  • 4Gradishar W J,Anderson B O,Balassanian R,et al.Invasive Breast Cancer Version 1.2016,NCCN Clinical Practice Guidelines in Oncology[J].J Natl Compr Canc Netw,2016,14(3):324-354.
  • 5Ettinger D S,Akerley W,Borghaei H,et al.Non-small cell lung cancer,version 2.2013.[J].J Natl Compr Canc Netw,2013,11(6):645-653.
  • 6Gonzalez-Rivas D,Paradela M,Fernandez R,et al.Uniportal video-assisted thoracoscopic lobectomy:two years of experience[J].Ann Thorac Surg,2013,95(2):426-432.
  • 7Bendixen M,Jrgensen O D,Kronborg C,et al.Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer:a randomised controlled trial[J].Lancet Oncol,2016,17(6):836-844.
  • 8Lee P C,Nasar A,Port J L,et al.Long-term survival after lobectomy for non-small cell lung cancer by video-assisted thoracic surgery versus thoracotomy.[J].Ann Thorac Surg,2013,96(3):951–960.
  • 9Higuchi M,Yaginuma H,Yonechi A,et al.Long-term outcomes after video-assisted thoracic surgery(VATS)lobectomy versus lobectomy via open thoracotomy for clinical stage IA non-small cell lung cancer[J].J Cardiothorac Surg,2013,9(1):1-7.
  • 10Jiang G,Yang F,Li X,et al.Video-assisted thoracoscopic surgery is more favorable than thoracotomy for administration of adjuvant chemotherapy after lobectomy for non-small cell lung cancer[J].World J Surg Oncol,2011,9(1):1-6.

引证文献10

二级引证文献121

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部